Detalhe da pesquisa
1.
OnabotulinumtoxinA effects on trigeminal nociceptors.
Cephalalgia
; 43(2): 3331024221141683, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36751871
2.
OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients.
Brain
; 145(7): 2436-2449, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932787
3.
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
Am Heart J
; 245: 51-59, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687654
4.
Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD.
Cephalalgia
; 42(9): 933-943, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332801
5.
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.
Cephalalgia
; 42(11-12): 1194-1206, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546268
6.
Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.
Aesthet Surg J
; 42(11): 1318-1327, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704394
7.
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.
Cephalalgia
; 41(1): 17-32, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200944
8.
Novel Native and Engineered Botulinum Neurotoxins.
Handb Exp Pharmacol
; 263: 63-89, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274579
9.
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
Headache
; 60(7): 1259-1272, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602955
10.
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
Headache
; 60(3): 564-575, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037549
11.
Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats.
Cephalalgia
; 39(11): 1358-1365, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475573
12.
Botulinum toxin type E associated with reduced itch and pain during wound healing and acute scar formation following excision and linear repair on the forehead: A randomized controlled trial.
J Am Acad Dermatol
; 89(6): 1317-1319, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666427
13.
Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.
Headache
; 57(1): 109-125, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27910097
14.
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
Headache
; 57(5): 766-777, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28387038
15.
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
Cephalalgia
; 36(9): 875-86, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26984967
16.
Pregnancy outcomes following exposure to onabotulinumtoxinA.
Pharmacoepidemiol Drug Saf
; 25(2): 179-87, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635276
17.
Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles.
Dermatol Surg
; 42(9): 1094-101, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27427996
18.
Neck Pain and Cervical Dystonia: Treatment Outcomes from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
Pain Pract
; 16(8): 1073-1082, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910788
19.
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
Pediatr Dermatol
; 32(5): 609-17, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059781
20.
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.
Cephalalgia
; 34(11): 853-69, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694964